Chou Judy - Jul 12, 2021 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Director
Signature
/ s/ Jonathan Young, attorney-in-fact
Stock symbol
AKRO
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
3
Date filed
7/14/2021, 04:08 PM
Next filing
Jun 3, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney